United States · FDA National Drug Code directory

DOXORUBICIN HYDROCHLORIDE

Source ingredient · 64 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 0143-9089_7c916380-3ae0-4a64-945d-7b0da46b9715

Doxorubicin Hydrochloride

INJECTION, SOLUTION / Hikma Pharmaceuticals USA Inc.

United States · Source reference 0143-9090_7c916380-3ae0-4a64-945d-7b0da46b9715

Doxorubicin Hydrochloride

INJECTION, SOLUTION / Hikma Pharmaceuticals USA Inc.

United States · Source reference 0143-9091_7c916380-3ae0-4a64-945d-7b0da46b9715

Doxorubicin Hydrochloride

INJECTION, SOLUTION / Hikma Pharmaceuticals USA Inc.

United States · Source reference 0143-9092_3b0d5f19-5eab-4729-8fbf-3b988cbc6d04

Doxorubicin Hydrochloride

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / Hikma Pharmaceuticals USA Inc.

United States · Source reference 0143-9093_3b0d5f19-5eab-4729-8fbf-3b988cbc6d04

Doxorubicin Hydrochloride

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / Hikma Pharmaceuticals USA Inc.

United States · Source reference 47335-049_efff8fef-d079-4581-8027-646e57a23c62

Doxorubicin Hydrochloride

INJECTABLE, LIPOSOMAL / Sun Pharmaceutical Industries, Inc.

United States · Source reference 47335-050_efff8fef-d079-4581-8027-646e57a23c62

Doxorubicin Hydrochloride

INJECTABLE, LIPOSOMAL / Sun Pharmaceutical Industries, Inc.

United States · Source reference 63323-101_89998b96-8ca7-4eb1-98a4-e533420d0e72

Doxorubicin Hydrochloride

INJECTION, SOLUTION / Fresenius Kabi USA, LLC

United States · Source reference 63323-883_89998b96-8ca7-4eb1-98a4-e533420d0e72

Doxorubicin Hydrochloride

INJECTION, SOLUTION / Fresenius Kabi USA, LLC

United States · Source reference 67457-436_fa646028-c150-4d9b-80a8-8add851d684d

Doxorubicin Hydrochloride

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / Mylan Institutional LLC

United States · Source reference 68001-345_e9b9ead5-4033-1599-e053-2a95a90a0d81

Doxorubicin Hydrochloride

INJECTABLE, LIPOSOMAL / BluePoint Laboratories

United States · Source reference 68001-492_525648ca-bf98-83d3-e063-6394a90a651b

Doxorubicin Hydrochloride

INJECTABLE, LIPOSOMAL / BluePoint Laboratories

United States · Source reference 68001-493_525648ca-bf98-83d3-e063-6394a90a651b

Doxorubicin Hydrochloride

INJECTABLE, LIPOSOMAL / BluePoint Laboratories

United States · Source reference 68083-248_b7814991-37d8-4928-ad83-d8fc04409c08

Doxorubicin Hydrochloride

INJECTION, SOLUTION / Gland Pharma Limited

United States · Source reference 68083-249_b7814991-37d8-4928-ad83-d8fc04409c08

Doxorubicin Hydrochloride

INJECTION, SOLUTION / Gland Pharma Limited

United States · Source reference 68083-250_b7814991-37d8-4928-ad83-d8fc04409c08

Doxorubicin Hydrochloride

INJECTION, SOLUTION / Gland Pharma Limited

United States · Source reference 70121-1218_f4a01f55-65d7-401f-ac2f-e1511bf3a429

Doxorubicin Hydrochloride

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / Amneal Pharmaceuticals LLC

United States · Source reference 70121-1219_f4a01f55-65d7-401f-ac2f-e1511bf3a429

Doxorubicin Hydrochloride

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / Amneal Pharmaceuticals LLC

United States · Source reference 72603-103_010a4e76-dedf-4f7b-b4de-1d78f91c2095

Doxorubicin Hydrochloride

INJECTABLE, LIPOSOMAL / NorthStar RxLLC

United States · Source reference 72603-200_010a4e76-dedf-4f7b-b4de-1d78f91c2095

Doxorubicin Hydrochloride

INJECTABLE, LIPOSOMAL / NorthStar RxLLC

United States · Source reference 0338-0080_dc55e584-6c92-4cd3-ad37-25029cf15368

Doxorubicin Hydrochloride Liposome

INJECTION, SUSPENSION, LIPOSOMAL / Baxter Healthcare Company

United States · Source reference 0338-0086_dc55e584-6c92-4cd3-ad37-25029cf15368

Doxorubicin Hydrochloride Liposome

INJECTION, SUSPENSION, LIPOSOMAL / Baxter Healthcare Company

United States · Source reference 25021-263_97cdef7c-93c7-4c7a-9a51-fc260a6a4521

Doxorubicin Hydrochloride Liposome

INJECTION, SUSPENSION, LIPOSOMAL / Sagent Pharmaceuticals

United States · Source reference 45963-733_2ad7c99b-8cea-4e22-826f-9e49c90605b6

Doxorubicin hydrochloride

INJECTION, SOLUTION / Actavis Pharma, Inc.

United States · Source reference 25021-207_f327fef8-8ebd-45a2-a339-72e702c4f8b5

doxorubicin hydrochloride

INJECTION, SOLUTION / Sagent Pharmaceuticals

United States · Source reference 46708-525_f8e001f5-441c-47cd-86f6-5d5e3de16bc0

doxorubicin hydrochloride

INJECTION, SUSPENSION, LIPOSOMAL / Alembic Pharmaceuticals Limited

United States · Source reference 46708-810_f8e001f5-441c-47cd-86f6-5d5e3de16bc0

doxorubicin hydrochloride

INJECTION, SUSPENSION, LIPOSOMAL / Alembic Pharmaceuticals Limited

United States · Source reference 62332-525_3c950b53-2ad7-432c-835c-eb7e92c348cf

doxorubicin hydrochloride

INJECTION, SUSPENSION, LIPOSOMAL / Alembic Pharmaceuticals Inc.

United States · Source reference 62332-810_3c950b53-2ad7-432c-835c-eb7e92c348cf

doxorubicin hydrochloride

INJECTION, SUSPENSION, LIPOSOMAL / Alembic Pharmaceuticals Inc.

United States · Source reference 68001-706_558895f3-e5b3-8e4e-e063-6294a90ad078

doxorubicin hydrochloride

INJECTION, SUSPENSION, LIPOSOMAL / BluePoint Laboratories

Browse ingredients in United States →